Position in ICLR
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,519,962
+$819,128 QoQ
Shares Held
8,750
+118.5% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#187
of 422 holders
Holding Since
Jun 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ICLR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026FOX RUN MANAGEMENT, L.L.C. holds $15,330,453 across 13 Diagnostics & Research names. ICLR ranks #5 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
4,967 | $2,614,827 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
4,373 | $2,192,447 | |
| 3 | GH |
Guardant Health, Inc.
|
14,194 | $2,129,525 | |
| 4 | NTRA |
Natera, Inc.
|
5,952 | $1,615,670 | |
| 5 | ICLR |
Icon PLC
This page
|
8,750 | $1,519,962 | |
| 6 | DHR |
Danaher Corp /De/
|
7,453 | $1,419,647 | |
| 7 | ILMN |
Illumina, Inc.
|
5,605 | $985,527 | |
| 8 | VCYT |
Veracyte, Inc.
|
11,062 | $649,671 |
All Filings in ICLR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,519,962 | 8,750 | Shares | Sole | 2026-08-04 | |
| 2025-03-31 | $700,834 | 4,005 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $241,585 | 1,152 | Shares | Sole | 2025-02-11 | |
| 2023-12-31 | $358,083 | 1,265 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $679,896 | 2,761 | Shares | Sole | 2023-11-07 | |
| 2023-03-31 | $280,230 | 1,312 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $559,245 | 2,879 | Shares | Sole | 2023-02-07 | |
| 2021-06-30 | $300,763 | 1,455 | Shares | Sole | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||